Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature revi...

por Spera, Anna Maria
Publicado 2021

Safety of direct acting antiviral treatment for hepatitis C in oncologic setting: A clinical experience and a literature review

por Spera, Anna Maria
Publicado 2022

Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment

por Spera, Anna Maria
Publicado 2022

Experimental Pharmacotherapy for COVID-19: The Latest Advances

por Pagliano, Pasquale, Scarpati, Giuliana, Sellitto, Carmine, Conti, Valeria, Spera, Anna Maria, Ascione, Tiziana, Piazza, Ornella, Filippelli, Amelia
Publicado 2021